UMass Chan Medical School is a public medical school in Worcester, Massachusetts. It is part of the University of Massachusetts system.

During the past decade, University of Massachusetts Medical School conducted 231 clinical trials. In the 10-year time frame, 231 clinical trials started and 150 clinical trials were completed, i.e. on average, 64.9% percent of trials that started reached the finish line to date. In the past 5 years, 107 clinical trials started and 86 clinical trials were completed. i.e. 80.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Massachusetts Medical School" #1 sponsor was "University of Massachusetts, Worcester" with 104 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 45 trials sponsored, "Children's Oncology Group" with 16 trials sponsored, "National Cancer Institute (NCI)" with 10 trials sponsored and "SWOG Cancer Research Network" with 10 trials sponsored. Other sponsors include 306 different institutions and companies that sponsored additional 198 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Massachusetts Medical School" #1 collaborator was "National Cancer Institute (NCI)" with 44 trials as a collaborator, "University of Massachusetts, Worcester" with 19 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 16 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 13 trials as a collaborator and "Bristol-Myers Squibb" with 9 trials as a collaborator. Other collaborators include 309 different institutions and companies that were collaborators in the rest 209 trials.

According to Clinical.Site data, the most researched conditions in "University of Massachusetts Medical School" are "HIV Infections" (50 trials), "Schizophrenia" (13 trials), "Obesity" (12 trials), "Amyotrophic Lateral Sclerosis" (9 trials) and "Recurrent Squamous Cell Lung Carcinoma" (8 trials). Many other conditions were trialed in "University of Massachusetts Medical School" in a lesser frequency.

Most popular intervention types in "University of Massachusetts Medical School" are "Drug" (256 trials), "Other" (76 trials), "Device" (74 trials), "Behavioral" (67 trials) and "Biological" (50 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (63 trials), "Laboratory Biomarker Analysis" (24 trials), "Zidovudine" (22 trials), "Didanosine" (11 trials) and "Nevirapine" (11 trials). Other intervention names were less common.

The vast majority of trials in "University of Massachusetts Medical School" are 449 trials for "All" genders, 35 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are 113 active trials in "University of Massachusetts Medical School". 3 are not yet recruiting, 61 are recruiting, 47 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 314 completed trials in University of Massachusetts Medical School, undefined suspended trials, and 36 terminated clinical trials to date.

Out of the total trials that were conducted in University of Massachusetts Medical School, 49 "Phase 1" clinical trials were conducted, 131 "Phase 2" clinical trials and 130 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 23 trials, and there were also 126 trials that are defined as “Not Applicable".

University of Massachusetts Medical School has several departments that took part in Clinical trials: "University of Massachusetts Medical School - Infectious Diseases and Immunology" - 4 trials, "University of Massachusetts Memorial Medical Center Department of Pediatrics" - 2 trials, "Univ of Massachusetts Med Ctr / Biotech II" - 2 trials